(Translated by https://www.hiragana.jp/)
Template:Nucleic acid inhibitors: Difference between revisions - Wikipedia Jump to content

Template:Nucleic acid inhibitors: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Ronhjones (talk | contribs)
m fix title
m wikify
Line 1: Line 1:
{{Navbox
{{Navbox
| name = Nucleic acid inhibitors
| name = Nucleic acid inhibitors
| title = [[Antibiotic|Antibacterials]]: [[nucleic acid inhibitor]]s ([[ATC code J01#J01E|J01E]], [[ATC code J01#J01M|J01M]])
| title = [[Antibiotic|Antibacterials]]: [[nucleic acid inhibitor]]s ([[ATC code J01#J01E|J01E]], [[ATC code J01#J01M|J01M]])
|listclass = hlist
| listclass = hlist


| groupstyle = background:PowderBlue;
| groupstyle = background:PowderBlue;


|group1 = [[Antifolate]]s<br />(inhibits<br/>[[purine metabolism]],<br />thereby inhibiting<br/> DNA and RNA synthesis)
| group1 = [[Antifolate]]s<br />(inhibits<br/>[[purine metabolism]],<br />thereby inhibiting<br/> DNA and RNA synthesis)
|list1 = {{Navbox subgroup
| list1 = {{Navbox|child
| groupstyle = background:PowderBlue;
| groupstyle = background:PowderBlue;


| group1 = [[Dihydrofolate reductase inhibitor|DHFR inhibitor]]
| group1 = [[Dihydrofolate reductase inhibitor|DHFR inhibitor]]
| list1 =
| list1 =
* ''[[2,4-Diaminopyrimidine]]'' ([[Trimethoprim]]<sup>#</sup>, [[Brodimoprim]]
* ''[[2,4-Diaminopyrimidine]]''
** [[Trimethoprim]]<sup>#</sup>
** [[Brodimoprim]]
* [[Tetroxoprim]]
** [[Tetroxoprim]]
* [[Iclaprim]]<sup>†</sup>)
** [[Iclaprim]]<sup>†</sup>


| group2 = [[sulfonamide (medicine)|Sulfonamides]]<br />([[Dihydropteroate synthetase inhibitor|DHPS inhibitor]])
| group2 = [[sulfonamide (medicine)|Sulfonamides]]<br />([[Dihydropteroate synthetase inhibitor|DHPS inhibitor]])
| list2 = {{Navbox subgroup
| list2 = {{Navbox|child
| groupstyle = background-color: PowderBlue
| groupstyle = background-color: PowderBlue


| group1 = [[Sulfonamide_(medicine)#Short-acting|Short-<br/>acting]]
| group1 = [[Sulfonamide_(medicine)#Short-acting|Short-<br/>acting]]
| list1 =
| list1 =
* [[Sulfisomidine|Sulfaisodimidine]]
* [[Sulfisomidine|Sulfaisodimidine]]
* [[Sulfamethizole]]
* [[Sulfamethizole]]
Line 27: Line 29:
* [[Sulfapyridine]]
* [[Sulfapyridine]]
* [[Sulfafurazole]]
* [[Sulfafurazole]]
* [[Sulfanilamide]] ([[Prontosil]])
* [[Sulfanilamide]]
** [[Prontosil]]
* [[Sulfathiazole]]
* [[Sulfathiazole]]
* [[Sulfathiourea]]
* [[Sulfathiourea]]


| group2 = [[Sulfonamide_(medicine)#Intermediate-acting|Intermediate-<br/>acting]]
| group2 = [[Sulfonamide_(medicine)#Intermediate-acting|Intermediate-<br/>acting]]
| list2 =
| list2 =
* [[Sulfamethoxazole]]
* [[Sulfamethoxazole]]
* [[Sulfadiazine]]<sup>#</sup>
* [[Sulfadiazine]]<sup>#</sup>
* [[Sulfamoxole]]
* [[Sulfamoxole]]


| group3 = [[Sulfonamide_(medicine)#Long-acting|Long-<br/>acting]]
| group3 = [[Sulfonamide_(medicine)#Long-acting|Long-<br/>acting]]
| list3 =
| list3 =
* [[Sulfadimethoxine]]
* [[Sulfadimethoxine]]
* [[Sulfalene]]
* [[Sulfalene]]
Line 52: Line 55:


| group5 = Other/ungrouped
| group5 = Other/ungrouped
| list5 =
| list5 =
* ''[[sulfanilamide]]'' ([[Sulfacetamide]]
* ''[[sulfanilamide]]''
** [[Sulfacetamide]]
* [[Sulfametrole]])
** [[Sulfametrole]]


| group6 = Combinations
| group6 = Combinations
| list6 =
| list6 =
* [[Trimethoprim/sulfamethoxazole]]<sup>#</sup>
* [[Trimethoprim/sulfamethoxazole]]<sup>#</sup>


}}
}}


|group2 = [[Topoisomerase inhibitor|Topoisomerase<br/> inhibitors]]/<br />[[quinolones]]/<br />(inhibits<br/>[[DNA replication]])
| group2 = [[Topoisomerase inhibitor|Topoisomerase<br/> inhibitors]]/<br />[[quinolones]]/<br />(inhibits<br/>[[DNA replication]])
|list2 = {{Navbox subgroup
| list2 = {{Navbox|child
| groupstyle = background:PowderBlue;
| groupstyle = background:PowderBlue;


| group1 = [[Fluoroquinolone#1st_generation|1st g.]]
| group1 = [[Fluoroquinolone#1st_generation|1st g.]]
| list1 =
| list1 =
* [[Cinoxacin]]<sup>‡</sup>
* [[Cinoxacin]]<sup>‡</sup>
* [[Flumequine]]
* [[Flumequine]]
Line 76: Line 80:
* [[Rosoxacin]]
* [[Rosoxacin]]


| group2 = [[Fluoroquinolone|Fluoro-<br />quinolone]]s
| group2 = [[Fluoroquinolone|Fluoro-<br />quinolone]]s
| list2 = {{Navbox subgroup
| list2 = {{Navbox|child
| groupstyle = background-color: PowderBlue
| groupstyle = background-color: PowderBlue


| group2 = [[Fluoroquinolone#2nd_generation|2nd g.]]
| group2 = [[Fluoroquinolone#2nd_generation|2nd g.]]
| list2 =
| list2 =
* [[Ciprofloxacin]]<sup>#</sup>
* [[Ciprofloxacin]]<sup>#</sup>
* [[Enoxacin]]<sup>‡</sup>
* [[Enoxacin]]<sup>‡</sup>
Line 92: Line 96:
* [[Rufloxacin]]
* [[Rufloxacin]]


| group3 = [[Fluoroquinolone#3rd_generation|3rd g.]]
| group3 = [[Fluoroquinolone#3rd_generation|3rd g.]]
| list3 =
| list3 =
* [[Balofloxacin]]
* [[Balofloxacin]]
* [[Grepafloxacin]]<sup>‡</sup>
* [[Grepafloxacin]]<sup>‡</sup>
Line 102: Line 106:
* [[Tosufloxacin]]
* [[Tosufloxacin]]


| group4 = [[Fluoroquinolone#4th_generation|4th g.]]
| group4 = [[Fluoroquinolone#4th_generation|4th g.]]
| list4 =
| list4 =
* [[Besifloxacin]]
* [[Besifloxacin]]
* [[Clinafloxacin]]<sup>†</sup>
* [[Clinafloxacin]]<sup>†</sup>
Line 114: Line 118:
* [[Prulifloxacin]]
* [[Prulifloxacin]]


| group5 = [[Fluoroquinolone#Veterinary_use|Vet.]]
| group5 = [[Fluoroquinolone#Veterinary_use|Vet.]]
| list5 =
| list5 =
* [[Danofloxacin]]
* [[Danofloxacin]]
* [[Difloxacin]]
* [[Difloxacin]]
Line 125: Line 129:
* [[Sarafloxacin]]
* [[Sarafloxacin]]


| group6 = Related ([[DNA gyrase|DG]])
| group6 = Related ([[DNA gyrase|DG]])
| list6 =
| list6 =
* [[Aminocoumarin]]s: [[Novobiocin]]
* [[Aminocoumarin]]s: [[Novobiocin]]


}}
}}



}}
}}


| group3 = [[Anaerobic organism|Anaerobic]] DNA<br />[[Nucleic_acid_inhibitor#DNA_inhibitors|inhibitors]]
| list3 = {{Navbox|child
| groupstyle = background-color: PowderBlue


| group1 = [[Nitroimidazole|Nitro-]] [[imidazole]] derivatives
| group3 = [[Anaerobic organism|Anaerobic]] DNA<br />[[Nucleic_acid_inhibitor#DNA_inhibitors|inhibitors]]
| list1 =
| list3 = {{Navbox subgroup
| groupstyle = background-color: PowderBlue

| group1 = [[Nitroimidazole|Nitro-]] [[imidazole]] derivatives
| list1 =
* [[Metronidazole]]<sup>#</sup>
* [[Metronidazole]]<sup>#</sup>
* [[Tinidazole]]
* [[Tinidazole]]
* [[Ornidazole]]
* [[Ornidazole]]


| group2 = [[Nitrofuran]] derivatives
| group2 = [[Nitrofuran]] derivatives
| list2 =
| list2 =
* [[Nitrofurantoin]]<sup>#</sup>
* [[Nitrofurantoin]]<sup>#</sup>
* [[Furazolidone]]<sup>‡</sup>
* [[Furazolidone]]<sup>‡</sup>
* [[Nifurtoinol]]
* [[Nifurtoinol]]





}}
}}


| group4 = [[RNA]] synthesis
| group4 = [[RNA]] synthesis
| list4 = {{Navbox subgroup
| list4 = {{Navbox|child
| groupstyle = background-color: PowderBlue
| groupstyle = background-color: PowderBlue


| group1 = [[Rifamycin]]s/<br/>[[RNA-dependent RNA polymerase|RNA polymerase]]

| list1 =
| group1 = [[Rifamycin]]s/<br/>[[RNA-dependent RNA polymerase|RNA polymerase]]
| list1 =
* [[Rifampicin]]
* [[Rifampicin]]
* [[Rifabutin]]
* [[Rifabutin]]
* [[Rifapentine]]
* [[Rifapentine]]
* [[Rifaximin]]
* [[Rifaximin]]





}}
}}
| belowstyle = background: transparent; padding: 0px;
| belowstyle = background: transparent; padding: 0px;
| below = {{PharmNavFootnote}}{{Bacteria navs}}
| below = {{PharmNavFootnote}}{{Bacteria navs}}


}}<noinclude>
}}<noinclude>

Revision as of 21:40, 10 February 2012